Compounds > cyclosporine

cyclosporine and Coronary Restenosis

cyclosporine has been researched along with Coronary Restenosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbonés, ML; Campanero, MR; Esteban, V; García-Redondo, AB; Jiménez-Borreguero, LJ; Méndez-Barbero, N; Novensá, L; Redondo, JM; Roqué, M; Salaices, M; Vila, L1
Arruda, JA; Barbosa, AH; Brito, FS; Costa, MA; Lima, VC; Pestana, JO; Ribeiro, EP; Tedesco, H1
Cleutjens, KB; Daemen, MJ; Donners, MM; Heeneman, S1
Mohr, FW; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M; Weinert, M1
Bartels, A; Breithardt, G; Hohage, H; Plenz, G; Schmidt, A; Sindermann, JR; Skaletz-Rorowski, A1

Reviews

1 review(s) available for cyclosporine and Coronary Restenosis

ArticleYear
Inflammation and restenosis: implications for therapy.
    Annals of medicine, 2003, Volume: 35, Issue:7

    Topics: Coronary Restenosis; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Inflammation Mediators; Sirolimus; Tacrolimus

2003

Trials

1 trial(s) available for cyclosporine and Coronary Restenosis

ArticleYear
Effect of systemic immunosuppression on coronary in-stent intimal hyperplasia in renal transplant patients.
    The American journal of cardiology, 2003, Jun-01, Volume: 91, Issue:11

    Topics: Azathioprine; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Cyclosporine; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Humans; Hyperplasia; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Stents; Tunica Intima

2003

Other Studies

3 other study(ies) available for cyclosporine and Coronary Restenosis

ArticleYear
Regulator of calcineurin 1 mediates pathological vascular wall remodeling.
    The Journal of experimental medicine, 2011, Sep-26, Volume: 208, Issue:10

    Topics: Aneurysm; Angiotensin II; Animals; Aorta; Calcineurin; Calcium-Binding Proteins; Cell Movement; Coronary Restenosis; Cyclosporine; Gene Expression Regulation; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle Proteins; Muscle, Smooth, Vascular; NFATC Transcription Factors; Rats; Rats, Wistar; Signal Transduction

2011
Cyclosporine does not enhance the development of accelerated coronary artery disease: experimental study in a rat cardiac transplant model.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2002, Volume: 21, Issue:4

    Topics: Animals; Cell Survival; Coronary Artery Disease; Coronary Restenosis; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Heart Rate; Heart Transplantation; Immunosuppressive Agents; Male; Models, Cardiovascular; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors; Treatment Outcome; Weight Gain; Withholding Treatment

2002
Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C.
    Basic research in cardiology, 2002, Volume: 97, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cattle; Cell Division; Cells, Cultured; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Cyclosporine; Enzyme Activation; Immunosuppressive Agents; Muscle, Smooth, Vascular; Paclitaxel; Protein Kinase C

2002